FULC compared with CMPX: revenue, margins and what each company keeps, and the suppliers and customers both name

FULCFulcrum Therapeutics, Inc.

Mkt capRevenueRevenue

CMPXCompass Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

FULCFulcrum Therapeutics, Inc.

CMPXCompass Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

FULC

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q1 FY26±19.3%▼−1.53%×0.08

Feb 24 '26±29.8%▼−21.21%×0.71

Oct 29 '25±18.7%▼−6.40%×0.34

Jul 29 '25±44.9%▼−2.82%×0.06

CMPX

0 of 3at or beyond implied

Reportimpliedrealized× implied

Q2 FY26—▲+5.29%—

May 5 '26±16.1%▲+0.52%×0.03

= impliedFULC realized, solidCMPX realized, hatchedOne scale, both sides: full bar = 53%× = |realized| ÷ impliedSource: market data

Q1 FY26

±52.0%

▼−2.81%

×0.05

Jan 6 '26±33.6%▼−1.60%×0.05

FULCFulcrum Therapeutics, Inc.

3.69▼−2.25%· post 3.69· delayed

Mkt cap$287.6MRevenue$80MQ2 FY24

CMPXCompass Therapeutics, Inc.

0.69▼−10.00%· post 0.69· delayed

After hoursNov 5 '26delayed

Mkt cap$137.4MRevenue$850,000Q2 FY24

Compare

After hoursNov 5 '26delayed

FULCFulcrum Therapeutics, Inc.

CMPXCompass Therapeutics, Inc.

3.69▼−2.25%post 3.69delayed

Price

0.69▼−10.00%post 0.69delayed

$287.6M

Mkt cap

$137.4M

Q2 FY24$80M

Revenue

$850,000Q2 FY24

FULC3.69▼−2.25%vsCMPX0.69▼−10.00%After hoursNov 5 '26delayed